Auteur A. H. LITWIN

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Effectiveness of a risk screener in identifying hepatitis C virus in a primary care setting

M. L. DRAINONI ; A. H. LITWIN ; B. D. SMITH ; E. A. KOPPELMAN ; M. D. McKEE ; C. L. CHRISTIANSEN ; A. L. GIFFORD ; C. M. WEINBAUM ; W. N. SOUTHERN | 2012
Dans American Journal of Public Health (Vol.102, n°11, November 2012) Article : Périodique

OBJECTIVES: We evaluated an intervention designed to identify patients at risk for hepatitis C virus (HCV) through a risk screener used by primary care providers. METHODS: A clinical reminder sticker prompted physicians at 3 urban clinics to s[...]

Plus d'info

Ajouter à la sélection

Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all

P. BRUGGMANN ; A. H. LITWIN | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : Périodique

One of the major obstacles to hepatitis C virus (HCV) care in people who inject drugs (PWID) is the lack of treatment settings that are suitably adapted for the needs of this vulnerable population. Nevertheless, HCV treatment has been delivered [...]

Plus d'info

Ajouter à la sélection

Nouveauté

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs [Commentary]

J. GREBELY ; J. BRUNEAU ; J. V. LAZARUS ; O. DALGARD ; P. BRUGGMANN ; C. TRELOAR ; M. HICKMAN ; M. HELLARD ; T. ROBERTS ; L. CROOKS ; H. MIDGARD ; S. LARNEY ; L. DEGENHARDT ; H. ALHO ; J. BYRNE ; J. F. DILLON ; J. J. FELD ; G. FOSTER ; D. GOLDBERG ; A. R. LLOYD ; J. REIMER ; G. ROBAEYS ; M. TORRENS ; N. WRIGHT ; I. MAREMMANI ; B. L. NORTON ; A. H. LITWIN ; G. J. DORE ; International Network on Hepatitis in Substance Users | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : Périodique

Globally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV) infection, including an estimated 7.5 million people who have recently injected drugs (PWID). There is an additional large, but unquantified, burden among th[...]

Plus d'info

Ajouter à la sélection

The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone

D. L. SYLVESTRE ; A. H. LITWIN ; B. J. CLEMENTS ; M. N. GOUREVITCH | 2005
Périodique

ENGLISH : Although most cases of hepatitis C virus (HCV) infection are associated with injection drug use, there are few data regarding the impact of putative barriers such as psychiatric disease and intercurrent drug use on HCV treatment outc[...]

Plus d'info

Ajouter à la sélection